FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064843 [Registered on: 27/03/2024] Trial Registered Prospectively
Last Modified On: 11/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effectiveness of amisulpride versus dexamethasone for control of nausea and vomiting after laparoscopic gall bladder removal operation. 
Scientific Title of Study   Efficacy of amisulpride versus dexamethasone for post operative nausea and vomiting prophylaxis in patients undergoing laparoscopic cholecystectomy- a randomized controlled trial. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Amit Pradhan 
Designation  Professor 
Affiliation  Kalinga Institute of Medical Sciences 
Address  Department of Anaesthesiology, Kalinga Institute of Medical Sciences,KIIT DEEMED TO BE UNIVERSITY, BHUBANESWAR,Khordha ,Odisha

Khordha
ORISSA
751024
India 
Phone  9437191002  
Fax    
Email  amitpdear@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sapna Das 
Designation  Assistant Professor 
Affiliation  KIMS, Bhubaneswar 
Address  Department of Anaesthesiology, Kalinga Institute of Medical Sciences ,KIIT DEEMED TO BE UNIVERSITY, BHUBANESWAR,Khordha ,Odisha

Khordha
ORISSA
751024
India 
Phone  9078826164  
Fax    
Email  dr.sapnadas88@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr K B Tharun Kumar 
Designation  Anaesthesiology junior resident 
Affiliation  KIMS, Bhubaneswar 
Address  Department of Anaesthesiology, Kalinga Institute of Medical Sciences ,KIIT DEEMED TO BE UNIVERSITY, BHUBANESWAR,Khordha ,Odisha

Khordha
ORISSA
751024
India 
Phone  7097091129  
Fax    
Email  kbtk786@gmail.com  
 
Source of Monetary or Material Support  
Kalinga Institute of Medical Sciences 
 
Primary Sponsor  
Name  Dr Amit Pradhan 
Address  Department of Anaesthesiology, Kalinga Institute of Medical Sciences,KIIT Deemed to be University,Bhubaneswar,Khordha,Odisha Pin-751024 India  
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr K B Tharun Kumar  PBMH,Kalinga Institute of Medical Sciences  Department of Anaesthesiology ,Kalinga Institute of Medical Sciences ,Bhubaneswar, Khordha ,Odisha pin-751024
Khordha
ORISSA 
7097091129

kbtk786@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE KALINGA INSTITUTE OF MEDICAL SCIENCES  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  , (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Amisulpride   Group A- will receive 5mg of Amisulpride  
Comparator Agent  Dexamethasone  Group D- will receive 8mg of Dexamethasone  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA 1& 2
Patients posted for elective Laparoscopic cholecystectomy under endotracheal general anaesthesia 
 
ExclusionCriteria 
Details  1.Any hypersensitivity to the study drugs
2.Administration of antiemetic/steroid 24 hrs prior to anaesthesia
3.Administration of Emetogenic anticancer chemotherapy in previous 4 weeks
4.Pregnant/lactating females
5.Patients on treatment with levodopa/ carbidopa
6.Cardiac arryhthmia, QT interval abnormality
7.Hypokalemia,hypomagnesemia
8.Pre-existing vestibular disease
9.Need of naso/oro-gastric tube after surgery
10.Requirement of post operative mechanical ventilation
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the proportion of Complete Response(defined as no episodes of nausea, retching or vomiting) upto first 24 hours after surgery  24hours 
 
Secondary Outcome  
Outcome  TimePoints 
1 Incidence and severity of significant nausea
2 Incidence of retching or vomiting
3 Time to first requirement of rescue antiemetic
4 Number of times of requirement of rescue antiemetic
5 VAS Score for pain
6 Adverse effects like infusion site pain, constipation and flatulence
 
24 hours 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Dexamethasone has been widely used to prevent nausea and vomiting. Amisulpride is recently shown to be effective in preventing vomiting. So we want to compare the efficacy of amisulpride versus dexamethasone in preventing post operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy under general anaesthesia.

PRIMARY OBJECTIVE : To compare the efficacy of Amisulpride versus Dexamethasone in prevention of post operative nausea and vomiting

SECONDARY OBJECTIVES:To compare the adverse effects in both the study groups.

 
Close